French international pioneer in respiratory health.

Based in Nice, this excellence center aims to develop innovative approaches for diagnosing, treating and preventing respiratory diseases.

Our Upcoming Events

Congrès international à Nice pour explorer l'impact de l’IA en pathologie thoracique et ses applications cliniques en santé respiratoire.
Events
AI in the Next World of Thoracic Pathology
10/06/2026
- 10/07/2026
In Nice, an international congress will explore the role of artificial intelligence in making thoracic pathology diagnosis faster, more precise and more personalized.
Visual for Pulmonary Fibrosis Day on 16 October 2026 in Nice, showing a woman with an illustration of the lungs.
Events
Pulmonary Fibrosis Day in Nice: Join Us on 16 October 2026
10/16/2026
On 16 October in Nice, patients, relatives, students, associations and healthcare professionals are invited to a day of information and workshops about pulmonary fibrosis.
Giant lung installed in Nice to raise awareness of smoking and respiratory diseases.
Events
Mois Sans Tabac 2026: RespirERA Institute Organises a Respiratory Health Event in Nice
11/04/2026
On 4 November 2026, IHU RespirERA will hold a free public event in Nice focusing on smoking prevention, respiratory health and screening.

Our News

Conférence
Liquid biopsy and lung cancer: Prof. Paul Hofman shares research perspectives
Prof. Paul Hofman took part in an international webinar to present the opportunities and challenges of liquid biopsy for the early detection of lung cancer.
Graduation ceremony for the MSc Biobanks & Complex Data Management: IHU RespirERA and Université Côte d'Azur celebrate 8 future biobanking experts.
News
Graduation ceremony for the MSc Biobanks and Complex Data Management
On Wednesday, September 23, 2026, 8 students received their diplomas upon completion of the Master of Science (MSc) Biobanks and Complex Data Management, jointly offered by Université Côte d'Azur and IHU RespirERA. This ceremony marked...
Journée inter-IHU 2026 à Marseille
Featured
Inter-IHU Day: RespirERA looks forward to sharing expertise in Marseille
On September 22 in Marseille, RespirERA will participate in the Inter-IHU Day to share expertise and experiences and explore new avenues for collaboration among institutes.

Our Strategic Priorities

IHU RespirERA structures its actions around four complementary strategic priorities. Together, they aim to improve the understanding and prevention of respiratory diseases, enhance their diagnosis, personalize patient care, and widely disseminate research-driven innovations for the benefit of patients and society.

Our Missions

IHU RespirERA is committed to five key missions to explore the impact of aging and the environment on respiratory health, placing the patient at the heart of its projects.
Understand

the mechanisms of respiratory diseases to better address them.

Prevent

by identifying environmental risk factors and developing effective prevention strategies.

Treat

by creating personalized treatments tailored to each patient’s specific needs.

Innovate

by integrating new technologies, including artificial intelligence and robotics, to enhance diagnosis and care.

Educate & Train

healthcare professionals and the general public on emerging technologies and best practices.

Our Strategy

IHU RespirERA is built on a synergy between researchers, clinicians, patient associations, and industry partners, fostering effective collaboration to understand and treat respiratory diseases. This holistic approach considers all aspects of these pathologies, from biological factors to environmental impacts, to develop comprehensive and innovative solutions. The Provence-Alpes-Côte d’Azur region, significantly affected by pollution and an aging population, serves as our "living laboratory", enabling us to develop real-world solutions tailored to environmental and health challenges.

Our Projects

Discover our flagship projects that need your support!

Liquid biopsy: a blood test to diagnose lung cancer
Toward more precise and less invasive diagnosis of lung cancer for better targeted treatments
Innovative biomarkers: tissue, liquid and AI
Towards earlier diagnosis and targeted treatments thanks to innovative biomarkers, liquid biopsy and AI.
Dépistage du cancer du poumon
IHU RespirERA is a leading actor in the deployment of lung cancer screening in France.

Support Us

to give new life to research!

By supporting IHU RespirERA, you are directly contributing to the funding of our innovative projects across all areas of respiratory health.

Every donation is a breath of fresh air for research.

Our Founding Members

Our Institutional Support

Supported by the ANR through France 2030: ANR-23-IAHU-0007